三联疗法联合利多卡因治疗慢性胃炎的疗效观察

目的探讨三联疗法联合利多卡因治疗慢性胃炎的临床疗效。方法选取2009年2月。2010年3月来我院进行治疗的66例慢性胃炎患者，随机分为对照组和观察组，每组33例。所有患者均先使用三联疗法治疗，对照组在此基础上加用吗丁啉，观察组则加用利多卡因。观察比较两组患者的临床疗效、幽门螺杆菌（Hp）根除率及不良反应。结果治疗后，观察组的总有效率、Hp根除率均明显高于对照组（P〈0．05）；上腹痛症及嗝气症的症状积分治疗后均比治疗前显著下降（P〈0．05），且观察组的积分低于对照组（P〈0．05）；两组均无严重的不良反应。结论三联疗法联合利多卡因治疗慢性胃炎能有效减轻炎症症状，根除幽门螺杆菌，提高患者的治愈率，临床疗效显著，适宜临床推广使用。

The Efficacy of Triple Therapy Combined Lidocaine in Treatment of Chronic Gastritis

Objective To discuss the efficacy of triple therapy combined lidocaine in treatment of chronic gastritis. Methods Sixty-six cases with chronic gastritis were selected from February 2009 to March 2010 in our hospital, they were randomly divided into the control group and the observation group, and each group had 33 cases. All of the patients were given triple therapy firstly; The control group was given domperidone while the observation group was received triple therapy and lidocaine, and then observed the clinical curative effect, eradication of helicobacter pylori （ Hp ） and the occur rate of adverse reaction. Results After the treatment, the total effective rate and eradication rate of Hp in the observation group was higher than the control group （P 〈 0.05 ） ; Symptoms scores of epigastric pain and belch gas disease of post-treatment were lower than pre-treatment （P 〈 0.05 ）, and the scores in the observation group were lower than the control group （P 〈 0.05 ） ; There was no severe adverse reactions in the two groups. Conclusion Triple therapy combined lidocaine in treatment of chronic gastritis can effectively reduce the inflammation symptoms, eradicate Hp, improve clinical curing rate, and the curative effect is notable, so it is suitable for promotion in clinic.